Compare DVA & SSNC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DVA | SSNC |
|---|---|---|
| Founded | 1994 | 1986 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Misc Health and Biotechnology Services | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.1B | 15.9B |
| IPO Year | 2003 | 2007 |
| Metric | DVA | SSNC |
|---|---|---|
| Price | $233.49 | $66.11 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | ★ $156.75 | $96.13 |
| AVG Volume (30 Days) | 701.6K | ★ 1.9M |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 1.55% |
| EPS Growth | N/A | ★ 5.00 |
| EPS | ★ 2.87 | 0.91 |
| Revenue | ★ $13,643,069,000.00 | $1,675,295,000.00 |
| Revenue This Year | $3.85 | $9.20 |
| Revenue Next Year | $3.07 | $4.69 |
| P/E Ratio | $82.14 | ★ $71.78 |
| Revenue Growth | 6.46 | ★ 13.09 |
| 52 Week Low | $101.00 | $61.40 |
| 52 Week High | $238.64 | $91.07 |
| Indicator | DVA | SSNC |
|---|---|---|
| Relative Strength Index (RSI) | 78.56 | 50.86 |
| Support Level | $145.58 | $65.15 |
| Resistance Level | N/A | $70.24 |
| Average True Range (ATR) | 6.03 | 1.71 |
| MACD | 1.61 | 0.09 |
| Stochastic Oscillator | 78.96 | 64.89 |
DaVita is one of the largest providers of dialysis services in the United States, boasting a market share of about 35%. The firm operates over 3,200 facilities worldwide, mostly in the US, and treats about 300,000 patients annually. Government payers dominate US dialysis reimbursement. DaVita receives about two-thirds of US sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. While commercial insurers represent only about 10% of US patients treated, they represent nearly all of the profits generated by DaVita in the US dialysis business.
SS&C Technologies provides software products and software-enabled services to a variety of customers primarily in financial services. Acquisitions are a large part of SS&C's history. SS&C GlobeOp provides fund administration services to alternative and traditional asset managers. In addition, SS&C provides portfolio accounting, portfolio management, trading, banking/lending, and other software to asset managers, banks, and financial advisors. SS&C's purchase of Intralinks makes it a leading player in virtual deal room solutions. With its 2018 purchase of DST Systems, SS&C gained a foothold in the healthcare industry with pharmacy health management solutions and medical claim administration services. In 2022, SS&C acquired robotic process automation software firm Blue Prism.